| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |